Evidence map›Paper›PMID 30317199›Full record

ArticleBMJ case reports2018

Toxic epidermal necrolysis: the red eye and red herrings in casualty.

Robert J Barry, Ulises Zanetto, Sai Kolli, Rupal Morjaria

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Robert J BarryDepartment of Ophthalmology, Queen Elizabeth Hospital Birmingham, Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-6435-0048
Ulises ZanettoDepartment of Histopathology, City Hospital, Birmingham, UK.
Sai KolliDepartment of Ophthalmology, Queen Elizabeth Hospital Birmingham, Birmingham, Birmingham, UK.
Rupal MorjariaDepartment of Ophthalmology, Queen Elizabeth Hospital Birmingham, Birmingham, Birmingham, UK.
Queen Elizabeth Hospital Birmingham · GBBirmingham City Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 38-year-old woman presented to casualty with bilateral red eyes associated with a recent upper respiratory tract infection. This was initially diagnosed as conjunctivitis, however systemic review revealed an erythematous facial and skin rash, mildly swollen lips and mild swallowing difficulties. The patient was referred for an urgent medical assessment, by which time she was found to have erythema affecting 54% of her body surface area and diagnosed with suspected toxic epidermal necrolysis (TEN). She rapidly deteriorated over 24 hours with a spreading blistering skin rash and airway compromise requiring urgent intubation and admission to the intensive treatment unit (ITU). Subsequent skin biopsies confirmed the diagnosis of TEN, attributed to recent use of ibuprofen. Treatment included broad-spectrum antibiotics and high-dose corticosteroids. The patient had a prolonged hospital stay and developed severe scarring of the ocular surface. She was discharged home and remains under continuing outpatient follow-up with ophthalmology and dermatology teams.

Indexed as

Adrenal Cortex HormonesAdultAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalConjunctivitisCritical CareDiagnosis, DifferentialFemaleHumansIbuprofenStevens-Johnson SyndromeAdrenal Cortex HormonesAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalIbuprofencontraindications and precautionsdermatologyophthalmologyunwanted effects / adverse reactions

Identifiers

PMID30317199
PMCPMC6194389
OpenAlexW2897473309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.